🇺🇸 FDA
Patent

US 12378277

SGLTS/DPP4 inhibitor and application thereof

granted A61PA61P3/00A61P3/10

Quick answer

US patent 12378277 (SGLTS/DPP4 inhibitor and application thereof) held by DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD.
Grant date
Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P3/00, A61P3/10